hotspot -WSS

hotspot

author：entertainment 2025-10-01 02:16:24 - browse：6

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Can medical device makers keep up in the race to treat obesity?

WSS

Poor hospice wound care hurts patients and families

Ransomware attacks on hospitals: Study outlines patient impact

Weight loss drug costs may need more research, senator suggests

Biogen nominates mother of director’s child to replace him on board

Patients, doctors are clashing about side effects of hormonal birth control

Astellas still sees hope in its gene therapy after four deaths

knowledge

hotspot

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Senate panel passes drug pricing bills, but drops one PBM reform

Apple is now the first public company to be valued at $3 trillion

Gain of function research would be limited under House proposal

Tori Bowie and the unacceptable rates of Black maternal death

Surge of respiratory disease in China has likely explanation

Novavax promises a turnaround & Lilly roils the obesity market

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Anesthesiologist group: stop taking Ozempic before surgery

World's first CRISPR

entertainment

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

FDA approves first new drug developed for postpartum depression

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

A daunting task: navigating dual Medicare, Medicaid eligibility

Novo: Oral version of Ozempic leads to 15% weight loss

hotspot

focus

hotspot

focus